Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
Key Highlights
- ➤Axsome (AXSM) will report third-quarter 2026 financial results November 2.
- ➤Results will be released before U.S. financial markets open.
- ➤Management will host an 8:00 a.m. Eastern conference call and business update.
NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update.
To participate in the live conference call, please dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international). A live webcast of the conference call can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at www.axsome.com. A replay of the conference call will be available on the Company’s website for approximately 30 days following the live event.
Get started
Create a free account to read the full story.